Oanæs, C., Roalsø, M. T. T., Alexeeva, M., & Søreide, K. (2025). Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility. Cancers, 17(20), 3364. https://doi.org/10.3390/cancers17203364
Chicago Style (17th ed.) CitationOanæs, Celine, Marcus T. T. Roalsø, Marina Alexeeva, and Kjetil Søreide. "Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility." Cancers 17, no. 20 (2025): 3364. https://doi.org/10.3390/cancers17203364.
MLA (9th ed.) CitationOanæs, Celine, et al. "Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility." Cancers, vol. 17, no. 20, 2025, p. 3364, https://doi.org/10.3390/cancers17203364.